Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

Related Posts

Ucore Receives US$1.8 Million DoD Payment to Build...

December 18, 2024

23andMe Collapses: DNA Testing Giant Files for Bankruptcy,...

March 26, 2025

Greenvale to Commence Alpha Test Program 7

May 2, 2025

Top 5 Canadian Mining Stocks This Week: GPM...

March 1, 2025

Boss Energy Boosts Stake in Laramide Resources to...

March 15, 2025

Lode Gold Updates US OTC Market Symbol to...

January 10, 2025

Gold Price Dips, Markets Stay Flat as Fed...

May 8, 2025

Presenting on Emerging Growth Conference 81 Day 1...

April 16, 2025

10 Biggest Cannabis Stocks in the US and...

December 28, 2024

Nuclear Fuels Acquires TenSleep Uranium Project with Athabasca...

March 4, 2025

Recent Posts

  • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!
  • S&P 500, Bitcoin & XLK: What the Charts Are Saying Now
  • MACD + ADX: Spot the Pullbacks Worth Trading
  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips
  • Republicans look to stop China’s ‘backdoor’ tariff dodging scheme

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!

    May 23, 2025

  • S&P 500, Bitcoin & XLK: What the Charts Are Saying Now

    May 23, 2025

  • MACD + ADX: Spot the Pullbacks Worth Trading

    May 23, 2025

  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips

    May 23, 2025

  • Republicans look to stop China’s ‘backdoor’ tariff dodging scheme

    May 23, 2025

  • Trump has not directed admin to declassify Biden docs on health ‘cover-up’

    May 23, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (365)
  • Investing (1,182)
  • Politics (1,474)
  • Stocks (478)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved